Effect of proton pump inhibitors on in Vitro activity of tigecycline against several common clinical pathogens

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ni, Wentao ^a   Cai, Xuejiu ^a   Liang, Beibei ^a   Cai, Yun ^a   Cui, Junchang ^a   Wang, Rui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTER;

ANTI-INFECTIVE AGENTS; BACTERIA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PROTON PUMP INHIBITORS;

EID: 84907020051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086715     Document Type: Article

References (14)

1. Pankey GA (2005) Tigecycline. J Antimicrob Chemother 56: 470-480.
2. Bradford PA, Weaver-Sands DT Petersen PJ (2005) In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials for complicated skin and skin structure infections and complicated intra-abdominal infections. Clin Infect Dis 41 Suppl 5: S315-332. (Pubitemid 41170379)
3. Sun Y, Cai Y, Liu X, Bai N, Liang B et al. (2013) The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents 41: 110-116.
4. Cordina C, Hill R, Deshpande A, Hood J, Inkster T (2012) Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J Antimicrob Chemother 67: 1806-1807.
5. Werner G, Gfrörer S, Fleige C, Witte W, Klare I (2008) Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 61: 1182-1183. (Pubitemid 351524469)
6. Yang Y, Chua KL (2013) Assessment of the effect of efflux pump inhibitors on in vitro antimicrobial susceptibility of multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 42: 283-284.
7. Clinical and Laboratory Standards Institute (2013) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement (M100-S23). CLSI, Wayne, PA, USA.
8. Clinical and Laboratory Standards Institute (2012) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition (M07-A9). CLSI, Wayne, PA, USA.
9. Petersen PJ, Labthavikul P, Jones CH, Bradford PA (2006) In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57: 573-576. (Pubitemid 43240214)
10. Zhang D, Zhang Y, Liu M, Wang X, Yang M, et al. (2013) Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects. Eur J Drug Metab Pharmacokinet 38: 209-215.
11. Wang Y, Zhang H, Meng L, Wang M, Yuan H, et al. (2010) Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers. Eur J Clin Pharmacol 66: 563-569.
12. Pue MA, Laroche J, Meineke I, De Mey C (1993) Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Eur J Clin Pharmacol 44: 575-578. (Pubitemid 23197845)
13. Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ (1999) Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus . Antimicrob Agents Chemother 43: 335-340. (Pubitemid 29079168)
14. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B et al. (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ K+) ATPase. Nature 290: 156-161.